TRANSACTION SUMMARY
DSK Legal advised HealthQuad Fund II (“HealthQuad”) in relation to its primary and secondary investment in the Series A funding round of GoApptiv Private Limited (“Company”) along with Cipla Limited (“Cipla”) as a co-investor, wherein Cipla is an existing investor in the Company.

The Company is involved in the ‘HealthTech’ space and is engaged in the business of providing end-to-end business services to healthcare companies for improving the reach of their products to different geo market segments. The Company’s “smart-shared platforms” aims at providing agile market access, optimize patient experiences, deliver organizational growth, and empowering every stakeholder in the healthcare ecosystem.

DSK Legal advised HealthQuad on: (a) conducting the legal due diligence on the Company; and (b) drafting, negotiating, and finalizing the transaction documents in relation to HealthQuad’s primary and secondary investment in the Company.

The DSK Legal team representing HealthQuad Fund II on the Transaction comprised of Rishi Anand (Partner), Nakul Batra (Associate Partner), Shreya Singh (Associate), and Snigdha Prakash (Associate).

Cipla Limited was represented by its in-house legal counsels.

GoApptiv Private Limited was represented by Malvi Ranchoddas & Co.

TRANSACTION SUMMARY

DSK Legal advised HealthQuad Fund II (“HealthQuad”) in relation to its subscription of securities in the Series B funding round of Redcliffe Lifetech Private Limited and Redcliffe Lifetech Inc. (“Investee Companies”), as one of the major investors along with Vistra ITCL (India) Limited, Amicorp Trustees (India) Private Limited, and Shubharambh Investment Holdings (Leap Frog) (“Transaction”).

The Investee Companies are engaged in the business providing diagnostics services including pathology (including but not limited to routine biochemistry, immunoassay, histopathology, microbiology, etc.), radiology, advanced genomic tests and services, both via online and offline channels.

DSK Legal advised HealthQuad on drafting, negotiating, and finalising: (a) the transaction documents in relation to HealthQuad’s investment in the Indian Investee Company; and (b) the transaction documents for its investment in the US Investee Company.

The DSK Legal team representing HealthQuad Fund II on the Transaction comprised of Rishi Anand (Partner), Nakul Batra (Associate Partner) and Snigdha Prakash (Associate).

The Investee Companies, i.e., Redcliffe Lifetech Private Limited and Redcliffe Lifetech Inc., were represented by Vertices Law.

Shardul Amarchand Mangaldas & Co. represented Shubharambh Investment Holdings (Leap Frog).